Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP714374.RAfu7ZzCbYq0An1qRh2Zq26hxhi6QGvTxTNbPZw_KgE58130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP714374.RAfu7ZzCbYq0An1qRh2Zq26hxhi6QGvTxTNbPZw_KgE58130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP714374.RAfu7ZzCbYq0An1qRh2Zq26hxhi6QGvTxTNbPZw_KgE58130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP714374.RAfu7ZzCbYq0An1qRh2Zq26hxhi6QGvTxTNbPZw_KgE58130_provenance.
- NP714374.RAfu7ZzCbYq0An1qRh2Zq26hxhi6QGvTxTNbPZw_KgE58130_assertion description "[The somatostatin receptor 2 (sst2) is the pharmacological target of somatostatin analogs that are widely used in the diagnosis and treatment of human neuroendocrine tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP714374.RAfu7ZzCbYq0An1qRh2Zq26hxhi6QGvTxTNbPZw_KgE58130_provenance.
- NP714374.RAfu7ZzCbYq0An1qRh2Zq26hxhi6QGvTxTNbPZw_KgE58130_assertion evidence source_evidence_literature NP714374.RAfu7ZzCbYq0An1qRh2Zq26hxhi6QGvTxTNbPZw_KgE58130_provenance.
- NP714374.RAfu7ZzCbYq0An1qRh2Zq26hxhi6QGvTxTNbPZw_KgE58130_assertion SIO_000772 24565897 NP714374.RAfu7ZzCbYq0An1qRh2Zq26hxhi6QGvTxTNbPZw_KgE58130_provenance.
- NP714374.RAfu7ZzCbYq0An1qRh2Zq26hxhi6QGvTxTNbPZw_KgE58130_assertion wasDerivedFrom befree-20150227 NP714374.RAfu7ZzCbYq0An1qRh2Zq26hxhi6QGvTxTNbPZw_KgE58130_provenance.
- NP714374.RAfu7ZzCbYq0An1qRh2Zq26hxhi6QGvTxTNbPZw_KgE58130_assertion wasGeneratedBy ECO_0000203 NP714374.RAfu7ZzCbYq0An1qRh2Zq26hxhi6QGvTxTNbPZw_KgE58130_provenance.
- befree-20150227 importedOn "2015-02-27" NP714374.RAfu7ZzCbYq0An1qRh2Zq26hxhi6QGvTxTNbPZw_KgE58130_provenance.